MARIANNE PARKER: Open Payments
NPI 1568937324 · LORAIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 23 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $103 |
| Janssen Pharmaceuticals, Inc | 5 | $80 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| Luye Pharma (USA) Ltd. | 2 | $32 |
| Lundbeck LLC | 1 | $19 |
| Braeburn Inc. | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
Products named: REXULTI, INVEGA SUSTENNA, Auvelity, UZEDY, INGREZZA, ERZOFRI EXTENDED-RELEASE, ABILIFY MAINTENA, SPRAVATO.
Industry payments across OH — which companies pay providers there.
